GlaxoSmithKline LLC v. Louisiana

U.S. Supreme Court

Question(s) Presented

Whether state sovereign immunity bars a federal court from binding a State to a Rule 23 class settlement as an absent member plaintiff based on the State’s failure to opt out of the class.

Tab Group